Gesamtlänge aller Episoden: 13 hours 28 minutes
Bayer AG is one of the most important German companies in the life science business. Now the organization is at a historic turning point, dealing with numerous lawsuits resulting from the acquisition of Monsanto, a pharmaceutical pipeline that is losing exclusivity, and a significant decline in market value over the past few years. This has also sparked investor discussions about the possibility of splitting up the company...
with Prof. Dr. Kai Andrejewski, CFO of Sixt SE/ Sixt Group
with Dr. Joachim Peerlings, Chair Managing Director of Keysight Technologies Germany
with Gillian Drakeford, former Head of Global Retail Experience at INTER IKEA Group
with Harald Wilhelm, CFO of the Mercedes Benz Group
with Christian Ladurner, CFO of Hensoldt AG
with Lars Kaestle, CFO and Managing Director at Breitling
with Eva Kienle, CFO and Executive Board Member at KWS Saat SE & Co. KGaA
with Sebastian Säuberlich, CFO of Westwing Group AG
with Dr Julian Deutz, CFO of Axel Springer SE